Together we Drive the Future

CRISPR & Genome Engineering

EARLY BIRD DISCOUNT! Register by Aug 18, 2017 to receive 20% off your registration!
Or register 3 for the price of 2 with the coupon code rcdvb!

registration button

Genomics & Big Data Summit

Next Generation Sequencing

Big Data Bioinformatics

CRISPR & Genome Engineering

Dear Colleague,

The 2nd CRISPR & Genome Engineering Conference is part of The Genomics & Big Data Summit and will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and discuss the most recent advances in CRISPR & Genome Engineering. Leading researchers will present on hot topics such as: therapeutic applications of CRISPR and genome engineering, discovery and mechanisms of CRISPR systems, and will discuss updates on current CRISPR technologies and techniques. In addition to scientific talks, dedicated networking sessions will allow attendees to better dialogue on how CRISPR & Genome Engineering will continue to impact biomedical research. We look forward to seeing you at the conference! Best regards, The 2017 Advisory Committee
2016 Advisory Board Members
Daniel Anderson, MIT
James Audia, Constellation
Gurumurthy Channabasavaiah, University of Nebraska Medical Center
Jacob Corn, University of California, Berkeley
John Feder, Bristol-Myers Squibb
Karen Glass, Albany College of Pharmacy
Ozge Gursoy Yuzugullu, Dana Farber Cancer Institute
Bence Gyorgy, Harvard University
Hella Kohlhof, 4SC
Dirk Hockemeyer, University Of California, Berkeley
Rob Howes, MedImmune
Winston Patrick Kuo, Predicine, Inc
Ite Laird-Offringa, USC
Marcello Maresca, AstraZeneca
Lorenz Mayr, AstraZeneca
Miguel Moreno-Mateos, Yale University
Pamela Munster, UCSF
Sunitha Nagrath, University of Michigan
Jonathan Northrup, Salarius Pharmaceuticals
Pablo Perez-Pinera, University of Illinois
John O’Leary, St. James’s Hospital; Biomedical Diagnostics
Charles Rotimi, National Human Genome Research Institute
Xiaobing Shi, MD Anderson
Myung Shin, Merck
Jesse Smith, Epizyme
Cesar Sommer, Pfizer (Rinat Cell Engineering Facility)
Jeff Stock, Pfizer
Paul Tumeh, UCLA
Ron Weiss, MIT
Haoquan Wu, Texas Tech University Health Science Center
Guangbin Xia, University Of Florida
Xiangru Xu, Yale University
Hao Yin, MIT
Bruce Zetter, Harvard Medical School
Sunny Zhou, Northeastern University